SCHEMBL22016316

SCHEMBL22016316

O=C(O)C1CCC(n2nnnc2S)CC1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
HSD11B1 P28845 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
DUSP3 P51452 1/20 0.37
HCAR3 P49019 1/20 0.34
ALDH1A1 P00352 6/20 0.33
LMNA P02545 4/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTT P42858 1/20 0.32
TSHR P16473 1/20 0.32
PLG P00747 1/20 0.32
PLAT P00750 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12435470 0.80 MEN1 (0.40) MEN1KMT2AHSD11B1L3MBTL1DUSP3
SCHEMBL1973469 0.76 MEN1 (0.38) MEN1KMT2AHSD11B1L3MBTL1DUSP3
SCHEMBL1973468 0.76 MEN1 (0.38) MEN1KMT2AHSD11B1L3MBTL1DUSP3
SCHEMBL31399939 0.76 TSHR (0.46) MEN1KMT2AL3MBTL1ALDH1A1LMNA
SCHEMBL12436080 0.67 MEN1 (0.38) MEN1KMT2AHSD11B1L3MBTL1HCAR3
SCHEMBL11587975 0.65 LMNA (0.39) MEN1KMT2AL3MBTL1DUSP3LMNA
SCHEMBL2586040 0.63 PDE7A (0.41) MEN1KMT2AHSD11B1L3MBTL1DUSP3
SCHEMBL31076314 0.63 NPC1 (0.36) MEN1KMT2ADUSP3ALDH1A1LMNA
Cyclopropane Carboxylic Acid SCHEMBL10800712 0.63
SCHEMBL36093 0.63 TSHR (0.61) MEN1KMT2ADUSP3ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020099652-A1 COMPOUNDS THAT SELECTIVELY AND EFFECTIVELY INHIBIT HAKAI-MEDIATED UBIQUITINATION, AS ANTI-CANCER DRUGS FUNDACIÓN PROFESOR NOVOA SANTOS (ES) 2020-05-22 WO disclosed